Mengmeng Ning

937 total citations
33 papers, 765 citations indexed

About

Mengmeng Ning is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Mengmeng Ning has authored 33 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Mengmeng Ning's work include Drug Transport and Resistance Mechanisms (12 papers), Diabetes Treatment and Management (11 papers) and Peptidase Inhibition and Analysis (3 papers). Mengmeng Ning is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Diabetes Treatment and Management (11 papers) and Peptidase Inhibition and Analysis (3 papers). Mengmeng Ning collaborates with scholars based in China, Hungary and Japan. Mengmeng Ning's co-authors include Ying Leng, Jianhua Shen, Ying Feng, Yangliang Ye, Lina Zhang, Hongliang Duan, Ming‐Wei Wang, Suling Huang, Na Li and Caihong Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Mengmeng Ning

33 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengmeng Ning China 16 249 246 186 171 105 33 765
Pranesh Kumar India 17 359 1.4× 90 0.4× 85 0.5× 74 0.4× 61 0.6× 56 807
Isha Rani India 15 217 0.9× 117 0.5× 51 0.3× 155 0.9× 47 0.4× 50 658
Garima Singhal United States 13 544 2.2× 81 0.3× 162 0.9× 140 0.8× 105 1.0× 24 1.3k
Pengcheng Wang United States 19 512 2.1× 253 1.0× 41 0.2× 63 0.4× 148 1.4× 39 1.3k
Guru R. Valicherla India 19 220 0.9× 83 0.3× 61 0.3× 34 0.2× 62 0.6× 32 662
Yun-Peng Diao China 16 232 0.9× 88 0.4× 52 0.3× 53 0.3× 45 0.4× 62 835
Yi Zheng China 19 370 1.5× 157 0.6× 41 0.2× 84 0.5× 58 0.6× 74 966
Tang Li-da China 15 319 1.3× 47 0.2× 183 1.0× 78 0.5× 48 0.5× 59 754
Ruibing Feng China 19 413 1.7× 73 0.3× 49 0.3× 38 0.2× 127 1.2× 37 766
Weiqiang Chen China 15 366 1.5× 133 0.5× 36 0.2× 47 0.3× 74 0.7× 37 842

Countries citing papers authored by Mengmeng Ning

Since Specialization
Citations

This map shows the geographic impact of Mengmeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Ning more than expected).

Fields of papers citing papers by Mengmeng Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengmeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Ning. The network helps show where Mengmeng Ning may publish in the future.

Co-authorship network of co-authors of Mengmeng Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Ning. A scholar is included among the top collaborators of Mengmeng Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Ning. Mengmeng Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Mengmeng, Yang Liu, Yan Fu, et al.. (2024). MiR-146a alleviates inflammatory bowel disease in mice through systematic regulation of multiple genetic networks. Frontiers in Immunology. 15. 1366319–1366319. 5 indexed citations
2.
Ning, Mengmeng, et al.. (2022). Design and exploration of gut-restricted bifunctional molecule with TGR5 agonistic and DPP4 inhibitory effects for treating ulcerative colitis. European Journal of Medicinal Chemistry. 242. 114697–114697. 6 indexed citations
3.
Ning, Mengmeng, et al.. (2021). Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio. Bioorganic & Medicinal Chemistry. 43. 116280–116280. 5 indexed citations
4.
Huang, Suling, Qingli Zhang, Zhuohui Zhao, et al.. (2021). Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl4-Induced NASH Mice and the Effect of Obeticholic Acid. Metabolites. 11(6). 374–374. 9 indexed citations
5.
Ning, Mengmeng, Hua Cao, Yangliang Ye, et al.. (2020). Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects. European Journal of Medicinal Chemistry. 203. 112619–112619. 8 indexed citations
6.
Ning, Mengmeng, et al.. (2020). Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. Acta Pharmacologica Sinica. 41(11). 1446–1456. 28 indexed citations
7.
Ning, Mengmeng, et al.. (2020). Research and Application of New Polybasic Acid. SHILAP Revista de lepidopterología. 165. 5024–5024. 3 indexed citations
8.
Huang, Suling, Mengmeng Ning, Yangliang Ye, et al.. (2019). TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice. Metabolism. 99. 45–56. 52 indexed citations
9.
Ning, Mengmeng, et al.. (2017). Research and application of multi-hydrogen acidizing technology of low-permeability reservoirs for increasing water injection. IOP Conference Series Earth and Environmental Science. 100. 12156–12156. 3 indexed citations
10.
Ning, Mengmeng, et al.. (2016). OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition. Acta Pharmacologica Sinica. 37(10). 1359–1369. 24 indexed citations
11.
Cao, Hua, Zhixiang Chen, Kai Wang, et al.. (2016). Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect. Scientific Reports. 6(1). 28676–28676. 46 indexed citations
12.
Duan, Hongliang, Mengmeng Ning, Jia Liu, et al.. (2014). 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists. European Journal of Medicinal Chemistry. 82. 1–15. 29 indexed citations
13.
Ning, Mengmeng, Cen Guo, Lina Zhang, et al.. (2013). Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold. European Journal of Medicinal Chemistry. 69. 55–68. 14 indexed citations
14.
Ye, Yangliang, Mengmeng Ning, Attila Mándi, et al.. (2013). Design, Synthesis, and Structure–Activity Relationships of 3,4,5‐Trisubstituted 4,5‐Dihydro‐1,2,4‐oxadiazoles as TGR5 Agonists. ChemMedChem. 8(7). 1210–1223. 27 indexed citations
15.
Huang, Suling, et al.. (2012). Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice. Acta Pharmacologica Sinica. 33(9). 1195–1203. 39 indexed citations
16.
Mao, Weiwei, Mengmeng Ning, Zhiqing Liu, et al.. (2012). Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators. Bioorganic & Medicinal Chemistry. 20(9). 2982–2991. 41 indexed citations
17.
Chen, Junhua, et al.. (2012). Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice. Bioorganic & Medicinal Chemistry Letters. 22(8). 2748–2752. 5 indexed citations
18.
Ye, Na, Fuying Li, Mengmeng Ning, et al.. (2012). Investigation on the oxidation of aryl oxiranylmethanols and the synthesis of 2-aryl-N-thiazolyl-oxirane-2-carboxamides as glucokinase activators. Tetrahedron Letters. 53(35). 4738–4742. 7 indexed citations
19.
Ning, Mengmeng, Chunhao Yang, Xueming Yan, et al.. (2007). Aza analogues of equol: Novel ligands for estrogen receptor β. Bioorganic & Medicinal Chemistry. 15(17). 5828–5836. 15 indexed citations
20.
Li, Na, et al.. (2006). Bioactive Compounds from Peperomia pellucida. Journal of Natural Products. 69(2). 247–250. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pranesh Kumar Breakdown of academic impact, for papers by Isha Rani Breakdown of academic impact, for papers by Garima Singhal Breakdown of academic impact, for papers by Pengcheng Wang Breakdown of academic impact, for papers by Guru R. Valicherla Breakdown of academic impact, for papers by Yun-Peng Diao Breakdown of academic impact, for papers by Yi Zheng Breakdown of academic impact, for papers by Tang Li-da Breakdown of academic impact, for papers by Ruibing Feng Breakdown of academic impact, for papers by Weiqiang Chen
Rankless by CCL
2026